Results 71 to 80 of about 14,079 (176)
Background Alternative splicing in the eighth exon C‐terminus of VEGF‐A (vascular endothelial growth factor‐A) results in the formation of proangiogenic VEGF165a and antiangiogenic VEGF165b isoforms.
Adarshini Raja, Vijay Ganta
doaj +1 more source
Changes in vascular endothelial growth factor (VEGF) in pulmonary vessels have been described in congenital diaphragmatic hernia (CDH) and may contribute to the development of pulmonary hypoplasia and hypertension; however, how the expression of VEGF ...
L. Sbragia +7 more
doaj +1 more source
Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye
VEGFR1 and 2 signaling have both been increasingly shown to mediate complications of ischemic retinopathies, including retinopathy of prematurity (ROP), age-related macular degeneration (AMD), and diabetic retinopathy (DR). This study evaluates the effects of blocking VEGFR1 and 2 on pathological angiogenesis and vascular leakage in ischemic ...
Hu Huang, Jikui Shen, Stanley A Vinores
openaire +4 more sources
PurposeTo evaluate the effects and underlying mechanisms of early and late subconjunctival injection of bevacizumab on the inhibition of corneal neovascularization (NV).MethodsCorneal NV was induced by closed eye contact lens wear followed by a silk ...
Wei-Li Chen +6 more
doaj +1 more source
Activation of the VEGFR1 Chromatin Domain [PDF]
Debasree Dutta +3 more
openaire +1 more source
The interaction between vascular endothelial growth factor (VEGF) and its receptors (VEGFR) has important implications in angiogenesis and cancer, which moved us to search for peptide derivatives able to block this protein–protein interaction.
Beatriz Balsera +6 more
doaj +1 more source
Combined Anti-PLGF and Anti-Endostatin Treatments Inhibit Ocular Hemangiomas
Background/Aims: The degree of neovascularization determines the aggressiveness of ocular hemangiomas (OH). So far, the anti-angiogenic treatments using either antagonists against vascular endothelial growth factor A (VEGF-A), or endostatin, do not ...
Hua Jiang +4 more
doaj +1 more source
Background/aim Rheumatoid arthritis (RA) is one of the most common autoimmune systemic inflammatory diseases presenting with chronic articular and extra articular manifestations resulting in high incidences of deformities, disabilities, morbidities, and ...
Ingy Ashmawy +3 more
doaj +1 more source
Background VEGF165a increases the expression of the microRNA-17-92 cluster, promoting developmental, retinal, and tumor angiogenesis. We have previously shown that VEGF165b, an alternatively spliced anti-angiogenic VEGF-A isoform, inhibits the VEGFR ...
Sonia Batan +5 more
doaj +1 more source
Previous studies have demonstrated that vascular endothelial growth factor (VEGF) can trigger angiogenesis as well as inflammation through binding to its membranous receptor-1 on endothelial and inflammatory cells.
Ebrahim Kouchaki +4 more
doaj

